• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 -103.40
(-0.40%)
Sensex
84,673.02 -277.93
( -0.33%)
Bank Nifty
58,899.25 -63.45
( -0.11%)
Nifty IT
35,975.20 -400.00
( -1.10%)
Global Indices
Nasdaq
46,604.53 -563.95
(-1.20%)
Dow Jones
6,692.71 -62.40
(-0.92%)
Hang Seng
48,833.62 -1,490.29
(-2.96%)
Nikkei 225
9,695.49 -2.88
(-0.03%)
Forex
USD-INR
88.65 -0.06
(-0.07%)
EUR-INR
103.02 -0.02
(-0.02%)
GBP-INR
116.73 0.00
(0.00%)
JPY-INR
0.57 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
37.7171887
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
9.87
19.74
EPS(TTM)
Face Value()
Div & Yield %
4.66
10
0
 

emmbi industries ltd
MRF Q2 PAT rises 12% YoY to Rs 526 cr; declares dividend of Rs 3/sh
Nov 14,2025
However, revenue from operations rose 7.23% year-on-year (YoY) to Rs 7,378.72 crore for the quarter ended 30 September 2025.

Profit before tax (PBT) for Q2 FY26 stood at Rs 698.66 crore, up 10.69% from Rs 631.18 crore reported in the same period last year.

Total expense increased 6.68% year on year to Rs 6,788.16 crore during the quarter. The cost of materials consumed was Rs 4,577.49 crore (down 3.45% YoY), while employee benefits expense stood at Rs 494.31 crore (up 3.47% YoY) during the period under review.

On the margins front, MRF’s operating margin rose to 9.23% in Q2 FY26 from 8.74% in Q2 FY25. Net profit margin also advanced to 7.02%, up from 6.73% a year earlier.

On a half-year basis, the company’s net profit fell 1.5% to Rs 1,026.11 crore on a 6.94% rise in revenue from operations to Rs 15,054.41 crore in H1 FY26 over H1 FY25.

MRF declared an interim dividend of Rs 3 per share for FY26. The record date is 11 November 2025, and the dividend will be paid on or after 5 December 2025.

MRF is engaged in the manufacture of rubber products such as tires, tubes, flaps, and tread rubber and/or trading in rubber and rubber chemicals.

Shares of MRF shed 0.40% to Rs 157,744.95 on the BSE.